Captor Therapeutics ® Investor Relations

      Investor Relations

      Information on a transaction in shares of the Company obtained pursuant to Article 19 of MAR

      Publication date: 2021-07-02
      Number: RB ESPI 23/2021

      Current report no. 23/2021

      Date of preparation: 2 July 2021

      Subject: Information on a transaction in shares of the Company obtained pursuant to Article 19 of MAR

      Legal basis: Article 19 sec. 3 of MAR – information on transactions executed by persons discharging managerial responsibilities

      The Management Board of Captor Therapeutics S.A. with its registered office in Wrocław (the “Company”) informs that it received from Paweł Holstinghausen Holsten, a member of the Supervisory Board of the Company, a notice of a transaction in shares of the Company referred to in Article 19 sec. 1 of MAR.

      The text of the notice constitutes an appendix to this report.


      Attachments: